CytoDyn is a clinical-stage biotechnology company based in Vancouver, Washington. It develops leronlimab, an investigational antibody targeting CCR5, for cancer and inflammatory conditions.
| Legal Name | CytoDyn Inc. |
|---|---|
| Company Operating Status | Active |
| Full Address | 1111 Main Street Suite 660 Vancouver, WA 98660 USA |
| Previous Name | CYTODYN INC |
| Stock Symbol | CYDY |
| Wellfound ID | cytodyn |
Email and phone for Cytodyn are available to signed-in members of CliffBio.
Sign in to view